K-Dense AI
AI agent platform for scientific and biotech analysis that accelerates research cycles through multi-agent systems
k-dense.ai ↗📍 Palo Alto, CA
Verified Data
“Based on $12M Series A funding in 2025 and 6-person team, typical B2B SaaS metrics suggest $500K-$2M ARR. Freemium model with $50 free credits and thousands of users indicates early revenue generation.”
“The platform's open-source component is used by "thousands worldwide" and K-Dense Web is trusted by "thousands of professionals"”
“The small core team includes **six listed individuals**”
Company Profile
Contact
Strategic Analysis
Strategy
Dual-track approach combining open-source Claude Scientific Skills (170+ skills) to drive adoption with premium K-Dense Web platform (200+ skills, 60 exclusive) for monetization. Targeting scientific and biotech professionals with freemium model to land customers and expand through advanced features. Betting on AI-native research workflows to compress traditional research cycles.
Tactics
Open-sourced core scientific skills repository to build developer community and drive platform adoption. Freemium model with $50 free credits removes friction for trial conversion. Heavy focus on scientific validation through Harvard Medical School partnership and real-world case studies like Structure Therapeutics due diligence.
Competitive Positioning
Differentiates from general AI tools by specializing in scientific and biotech analysis with domain-specific multi-agent orchestration. Positions against standalone LLMs by offering hierarchical, multi-agent framework that significantly outperforms on bioinformatics challenges. Premium positioning through exclusive skills and publication-ready outputs.
Marketing Approach
Content-led growth through detailed case studies and technical blog posts demonstrating real-world applications. Academic validation and partnerships with institutions like Harvard Medical School for credibility. Open-source community building to drive awareness and platform adoption among scientific professionals.
Notable
YC-backed, validated by Harvard Medical School Professor David Sinclair, investors include Anthropic and 10x Genomics founders
🔗 Source ↗Tech Stack
Recent News
Related AI Agent Companies
Discovery Sources
Signals
“The platform's open-source component is used by "thousands worldwide" and K-Dense Web is trusted by "thousands of professionals"”
“The K-Dense team, based in Palo Alto, California, includes **6 named individuals** on its "About Us" page, including Co-Founder & Head of AI, Timothy Kassis, PhD”
“its open-source component, Claude Scientific Skills, boasts **100k+ users worldwide** [5], and K-Dense Web is used by "thousands of professionals"”
“Biostate AI secured $12 million in Series A funding led by Accel earlier in 2025”
“The K-Dense team comprises at least **6 individuals** listed on their "About Us" page”
“K-Dense Web is used by "thousands of professionals" and K-Dense Beta is being validated with "dozens of design partners"”
Evidence
A comprehensive collection of 170+ ready-to-use scientific and research skills (now including cancer genomics, drug-target binding, molecular dynamics, RNA velocity, geospatial science, time series forecasting, FRED economic data, and more) for any AI agent that supports the open Agent Skills standard, created by K-Dense.
$12M Series A led by Accel
Run the pip install academic-research-skills command and try `/ars-plan` to walk through your paper structure via Socratic dialogue.